(a)
- (1) On receipt of a petition for assisted outpatient treatment that meets the requirements of § 10-6A-04 of this subtitle, the court shall schedule the date for a hearing.
- (2) The court may grant a continuance or postponement only for good cause shown.
- (3) A hearing shall be scheduled only if the respondent has not agreed to enter voluntary treatment.
(b)
- (1) The respondent shall be entitled to be represented by counsel of the respondent's choice at the hearing and at all stages of the proceedings.
- (2) If the respondent is unable to afford an attorney, or is unable to obtain an attorney due to the respondent's mental illness, representation shall be provided in accordance with §§ 16-204 and 16-208 of the Criminal Procedure Article.
- (3) All rules of civil procedure shall apply to cases filed under this subtitle.
- (4) Respondents may not be required to give testimony at hearings under this subtitle.
- (5) Participation in assisted outpatient treatment may not be used against a respondent in a subsequent legal matter that carries negative collateral consequences.
- (c) At the hearing, the respondent shall be given an opportunity to present evidence, to call witnesses on the respondent's behalf, and to cross-examine adverse witnesses.
(d)
- (1) The petitioner's presentation of evidence shall include the testimony of a psychiatrist whose most recent examination of the respondent occurred within 30 days before the date of the petition.
- (2) The psychiatrist shall state the facts and clinical determinations providing the basis for the psychiatrist's opinion that the respondent meets each of the criteria for assisted outpatient treatment in § 10-6A-05 of this subtitle.
(e)
(1) The petitioner's presentation of evidence shall include the testimony of a psychiatrist to explain the treatment plan, who:
- (i) May be but need not be the examining psychiatrist who testified under subsection (d) of this section; and
- (ii) Has met with the respondent or has made a good faith effort to meet with the respondent, is familiar with the relevant history, to the extent practicable, and has examined the treatment plan.
- (2) For each category of proposed treatment, the psychiatrist shall state the clinical basis for the determination that the treatment is essential to the maintenance of the respondent's health or safety.
- (3) The psychiatrist shall testify as to the participation, if any, of the respondent in the development of the treatment plan.
Added by Acts 2024, c. 703, § 1, eff. July 1, 2025; Acts 2024, c. 704, § 1, eff. July 1, 2025.